PMD Psychemedics: Market Capitalization to Book Value Ratio

Official company branding of Psychemedics Inc (PMD)

Psychemedics maintains its leadership in the hair analysis sector, offering benchmark diagnostic accuracy over a 90-day period. Changes in the market value to book capitalization ratio help assess asset quality, with the metric currently standing at 2.91. Company revenues are moderately dependent on corporate hiring rates. The business is currently focusing on organic sales growth, having temporarily pivoted away from mergers.

Psychemedics Inc (PMD): Capitalization to Book Value Ratio from 07/04/2022 to 12/21/2024
Core merchandise of Psychemedics Corp.

Stable medical analysis contracts provide a reliable net asset base for Psychemedics (PMD). This multiple compares the current market value of the business with its book value. By analyzing the historical relationship between market cap and book value, an investor assesses the market premium over equity. An increase in this metric reflects confidence in future earnings, while a decrease indicates a risk of overvaluation. This allows for the real-time assessment of market sentiment between quarterly reports.

Main competitors

A (Agilent Technologies) - Market Value to Book Value Ratio|questdiagnostics.com (DGX) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio ILMN (Illumina)|Market-to-Book Ratio Exact Sciences Corp|Market Capitalization to Book Value Ratio PerkinElmer RVTY|Capitalization to Book Value Ratio Bio-Rad Corp (BIO)|Market Capitalization to Book Value Ratio NNNN (Anbio Biotechnology)|soterahealth.com - Market Capitalization to Book Value Ratio|QuidelOrtho Corporation (QDEL) - Market Value to Book Value Ratio|OPK - Capitalization to Book Value Ratio|CDNA: Market Capitalization to Book Value Ratio|MRVI (Maravai) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Fulgent Genetics, Inc.|Market Value to Book Value Ratio fluidigm.com (LAB)|Cytek Biosciences - Market Cap to Net Assets Ratio|Market-to-Book Ratio OSUR (OraSure Technologies, Inc.)|Market Value to Book Value Ratio XGN|Market Capitalization to Book Value MDxHealth, Inc. MDXH|Market Capitalization to Book Value Ratio LUCD (Lucid Diagnostics Inc.)|PRE: Market Capitalization to Book Value|imdxinc.com - Market Value to Book Value Ratio|TRIB (Trinity Biotech) - Market Capitalization to Book Value|Market Value to Book Value Ratio ProPhase PRPH|Market Capitalization to Net Assets AIMD|CODX (Co-Diagnostics, Inc.) - Market Value to Book Value Ratio|Market Capitalization to Book Value heartsciences.com HSCS|BMRA: Market Cap to Net Assets Ratio|Market-to-Book Ratio Cardio Diagnostics Holdings Inc. CDIO|VRAX: Market Capitalization to Book Value Ratio|BJDX - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Aspira Women's Health AWH|acceleratediagnostics.com (AXDX) - Market Value to Book Value|Market Capitalization to Book Value Ratio CNTG (CENTOGENE N.V.)|Market-to-Book Ratio ENZ|Market Value to Book Value Ratio FRES (Fresh2 Group Limited)|Market Cap to Net Assets Ratio gtglabs.com (GENE)|ME: Market Capitalization to Book Value Ratio